Impaired Inactivation of L-Type Ca2+ Current as a Potential Mechanism for Variable Arrhythmogenic Liability of HERG K+ Channel Blocking Drugs.
The proarrhythmic effects of new drugs have been assessed by measuring rapidly activating delayed-rectifier K+ current (IKr) antagonist potency. However, recent data suggest that even drugs thought to be highly specific IKr blockers can be arrhythmogenic via a separate, time-dependent pathway such a...
Main Authors: | Jae Gon Kim, Dong Jun Sung, Hyun-ji Kim, Sang Woong Park, Kyung Jong Won, Bokyung Kim, Ho Chul Shin, Ki-Suk Kim, Chae Hun Leem, Yin Hua Zhang, Hana Cho, Young Min Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4772914?pdf=render |
Similar Items
-
A molecular switch driving inactivation in the cardiac K+ channel HERG.
by: David A Köpfer, et al.
Published: (2012-01-01) -
Early identification of hERG liability in drug discovery programs by automated patch clamp
by: Timm eDanker, et al.
Published: (2014-09-01) -
Ca2+ current facilitation is CaMKII-dependent and has arrhythmogenic consequences
by: Donald M Bers, et al.
Published: (2014-06-01) -
Evolutionary analyses of KCNQ1 and HERG voltage-gated potassium channel sequences reveal location-specific susceptibility and augmented chemical severities of arrhythmogenic mutations
by: Accili Eric A, et al.
Published: (2008-06-01) -
Impact of arrhythmogenic calmodulin variants on small conductance Ca2+‐activated K+ (SK3) channels
by: Arnela Saljic, et al.
Published: (2019-10-01)